2018 Form 10-K Financial Statement
#000101008619000007 Filed on March 06, 2019
Income Statement
| Concept | 2018 | 2017 Q4 | 2017 Q3 |
|---|---|---|---|
| Revenue | $477.1M | $1.412M | $1.390M |
| YoY Change | 3788.3% | -80.39% | -70.43% |
| Cost Of Revenue | $95.27M | $0.00 | |
| YoY Change | |||
| Gross Profit | $381.8M | $1.390M | |
| YoY Change | 3011.79% | ||
| Gross Profit Margin | 80.03% | 100.0% | |
| Selling, General & Admin | $12.88M | $3.281M | $3.094M |
| YoY Change | 4.69% | -26.5% | 8.37% |
| % of Gross Profit | 3.37% | 222.59% | |
| Research & Development | $13.02M | $2.781M | $2.471M |
| YoY Change | -21.96% | -65.91% | -59.28% |
| % of Gross Profit | 3.41% | 177.77% | |
| Depreciation & Amortization | $69.63K | $20.00K | $29.38K |
| YoY Change | -47.33% | -50.0% | -31.14% |
| % of Gross Profit | 0.02% | 2.11% | |
| Operating Expenses | $122.0M | $6.062M | $7.041M |
| YoY Change | 291.91% | -51.97% | -44.65% |
| Operating Profit | $355.1M | -$4.871M | -$5.651M |
| YoY Change | -1983.9% | -26.3% | -29.91% |
| Interest Expense | $15.48M | -$7.900M | $3.737M |
| YoY Change | 4.88% | 154.84% | 3843.17% |
| % of Operating Profit | 4.36% | ||
| Other Income/Expense, Net | $78.94M | $0.00 | $2.021K |
| YoY Change | 470122.69% | -100.0% | -93.43% |
| Pretax Income | $411.6M | -$12.70M | $9.700M |
| YoY Change | -1173.96% | 22.12% | 5.43% |
| Income Tax | -$10.17M | $300.0K | $134.7K |
| % Of Pretax Income | -2.47% | 1.39% | |
| Net Earnings | $421.8M | -$10.30M | -$9.816M |
| YoY Change | -1264.07% | -1.3% | 6.19% |
| Net Earnings / Revenue | 88.42% | -729.67% | -706.19% |
| Basic Earnings Per Share | $5.28 | -$0.46 | -$0.12 |
| Diluted Earnings Per Share | $5.18 | -$0.46 | -$0.12 |
| COMMON SHARES | |||
| Basic Shares Outstanding | 79.92M | 78.87M shares | 78.91M shares |
| Diluted Shares Outstanding | 82.71M | 78.87M shares | 78.91M shares |
Balance Sheet
| Concept | 2018 | 2017 Q4 | 2017 Q3 |
|---|---|---|---|
| SHORT-TERM ASSETS | |||
| Cash & Short-Term Investments | $100.7M | $19.90M | $25.80M |
| YoY Change | 406.03% | -30.66% | 25.85% |
| Cash & Equivalents | $100.7M | $19.86M | $25.80M |
| Short-Term Investments | |||
| Other Short-Term Assets | $15.80M | $12.70M | $11.50M |
| YoY Change | 24.41% | 14.41% | 19.79% |
| Inventory | $2.900M | $2.983M | $2.983M |
| Prepaid Expenses | |||
| Receivables | $2.000M | $1.802M | $612.2K |
| Other Receivables | $0.00 | $0.00 | $0.00 |
| Total Short-Term Assets | $121.3M | $37.36M | $40.89M |
| YoY Change | 224.33% | -45.97% | -52.77% |
| LONG-TERM ASSETS | |||
| Property, Plant & Equipment | $200.0K | $138.6K | $119.7K |
| YoY Change | 100.0% | -53.71% | -63.73% |
| Goodwill | $898.3K | $898.3K | |
| YoY Change | 0.0% | 0.0% | |
| Intangibles | |||
| YoY Change | |||
| Long-Term Investments | |||
| YoY Change | |||
| Other Assets | $81.10M | $702.2K | $642.1K |
| YoY Change | -23.71% | 9.36% | 0.0% |
| Total Long-Term Assets | $82.10M | $107.3M | $107.8M |
| YoY Change | -23.49% | 16.86% | 41.4% |
| TOTAL ASSETS | |||
| Total Short-Term Assets | $121.3M | $37.36M | $40.89M |
| Total Long-Term Assets | $82.10M | $107.3M | $107.8M |
| Total Assets | $203.4M | $144.7M | $148.7M |
| YoY Change | 40.57% | -10.13% | -8.67% |
| SHORT-TERM LIABILITIES | |||
| YoY Change | |||
| Accounts Payable | $1.700M | $1.329M | $1.362M |
| YoY Change | 30.77% | -47.21% | -53.43% |
| Accrued Expenses | $5.500M | $5.482M | $4.321M |
| YoY Change | 30.95% | 19.56% | -9.85% |
| Deferred Revenue | |||
| YoY Change | |||
| Short-Term Debt | $0.00 | $0.00 | $0.00 |
| YoY Change | |||
| Long-Term Debt Due | |||
| YoY Change | |||
| Total Short-Term Liabilities | $11.30M | $6.810M | $13.04M |
| YoY Change | 66.18% | -4.1% | -87.96% |
| LONG-TERM LIABILITIES | |||
| Long-Term Debt | $75.50M | $71.10M | $69.90M |
| YoY Change | 6.19% | 6.76% | |
| Other Long-Term Liabilities | $13.60M | $389.9M | $378.3M |
| YoY Change | -96.51% | 4.11% | 2.97% |
| Total Long-Term Liabilities | $89.10M | $461.0M | $448.2M |
| YoY Change | -80.67% | 4.51% | 21.99% |
| TOTAL LIABILITIES | |||
| Total Short-Term Liabilities | $11.30M | $6.810M | $13.04M |
| Total Long-Term Liabilities | $89.10M | $461.0M | $448.2M |
| Total Liabilities | $100.5M | $467.8M | $461.6M |
| YoY Change | -78.52% | 4.33% | -3.04% |
| SHAREHOLDERS EQUITY | |||
| Retained Earnings | -$537.4M | -$527.1M | |
| YoY Change | 7.23% | 7.41% | |
| Common Stock | $214.2M | $214.2M | |
| YoY Change | 0.24% | 20.68% | |
| Preferred Stock | |||
| YoY Change | |||
| Treasury Stock (at cost) | |||
| YoY Change | |||
| Treasury Stock Shares | |||
| Shareholders Equity | $102.9M | -$323.1M | -$312.8M |
| YoY Change | |||
| Total Liabilities & Shareholders Equity | $203.4M | $144.7M | $148.7M |
| YoY Change | 40.57% | -10.13% | -8.67% |
Cashflow Statement
| Concept | 2018 | 2017 Q4 | 2017 Q3 |
|---|---|---|---|
| OPERATING ACTIVITIES | |||
| Net Income | $421.8M | -$10.30M | -$9.816M |
| YoY Change | -1264.07% | -1.3% | 6.19% |
| Depreciation, Depletion And Amortization | $69.63K | $20.00K | $29.38K |
| YoY Change | -47.33% | -50.0% | -31.14% |
| Cash From Operating Activities | $68.87M | -$8.160M | -$7.620M |
| YoY Change | -474.57% | -68.49% | -86.45% |
| INVESTING ACTIVITIES | |||
| Capital Expenditures | $102.3K | -$50.00K | -$10.00K |
| YoY Change | 2.14% | 400.0% | |
| Acquisitions | |||
| YoY Change | |||
| Other Investing Activities | $78.34M | $0.00 | |
| YoY Change | -100.0% | ||
| Cash From Investing Activities | $78.24M | -$50.00K | -$10.00K |
| YoY Change | -78239.67% | -104.17% | |
| FINANCING ACTIVITIES | |||
| Cash Dividend Paid | |||
| YoY Change | |||
| Common Stock Issuance & Retirement, Net | $0.00 | ||
| YoY Change | -100.0% | ||
| Debt Paid & Issued, Net | $0.00 | ||
| YoY Change | |||
| Cash From Financing Activities | -$3.813M | -340.0K | 0.000 |
| YoY Change | 551.09% | -100.56% | -100.0% |
| NET CHANGE | |||
| Cash From Operating Activities | $68.87M | -8.160M | -7.620M |
| Cash From Investing Activities | $78.24M | -50.00K | -10.00K |
| Cash From Financing Activities | -$3.813M | -340.0K | 0.000 |
| Net Change In Cash | $143.3M | -8.550M | -7.630M |
| YoY Change | -851.32% | -123.96% | -86.74% |
| FREE CASH FLOW | |||
| Cash From Operating Activities | $68.87M | -$8.160M | -$7.620M |
| Capital Expenditures | $102.3K | -$50.00K | -$10.00K |
| Free Cash Flow | $68.77M | -$8.110M | -$7.610M |
| YoY Change | -471.99% | -68.68% | -86.47% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2018 | dei |
Amendment Flag
AmendmentFlag
|
false | |
| CY2018 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | |
| CY2018 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
FY | |
| CY2018 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2018 | |
| CY2018 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2018-12-31 | |
| CY2018 | dei |
Document Type
DocumentType
|
10-K | |
| CY2018 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001010086 | |
| CY2019Q1 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
80941524 | shares |
| CY2018 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
| CY2018 | dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
false | |
| CY2018 | dei |
Entity Filer Category
EntityFilerCategory
|
Accelerated Filer | |
| CY2018Q2 | dei |
Entity Public Float
EntityPublicFloat
|
314197559 | USD |
| CY2018 | dei |
Entity Registrant Name
EntityRegistrantName
|
SIGA TECHNOLOGIES INC | |
| CY2018 | dei |
Entity Shell Company
EntityShellCompany
|
false | |
| CY2018 | dei |
Entity Small Business
EntitySmallBusiness
|
false | |
| CY2018 | dei |
Entity Voluntary Filers
EntityVoluntaryFilers
|
No | |
| CY2018 | dei |
Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
|
No | |
| CY2018 | dei |
Trading Symbol
TradingSymbol
|
SIGA | |
| CY2017Q4 | siga |
Accrued Researchand Development Vendor Costs Current
AccruedResearchandDevelopmentVendorCostsCurrent
|
183856 | USD |
| CY2018Q4 | siga |
Accrued Researchand Development Vendor Costs Current
AccruedResearchandDevelopmentVendorCostsCurrent
|
1446410 | USD |
| CY2018Q4 | siga |
Amount Received From Contractfor Developmentand Support Activities
AmountReceivedFromContractforDevelopmentandSupportActivities
|
43900000 | USD |
| CY2016 | siga |
Backstop Fee
BackstopFee
|
1764240 | USD |
| CY2017 | siga |
Backstop Fee
BackstopFee
|
0 | USD |
| CY2018 | siga |
Backstop Fee
BackstopFee
|
0 | USD |
| CY2018Q3 | siga |
Cash Consideration Received
CashConsiderationReceived
|
375600000 | USD |
| CY2016 | siga |
Collateralfor Surety Bond
CollateralforSuretyBond
|
1212591 | USD |
| CY2017 | siga |
Collateralfor Surety Bond
CollateralforSuretyBond
|
0 | USD |
| CY2018 | siga |
Collateralfor Surety Bond
CollateralforSuretyBond
|
0 | USD |
| CY2017Q4 | siga |
Computer Equipment
ComputerEquipment
|
701762 | USD |
| CY2018Q4 | siga |
Computer Equipment
ComputerEquipment
|
618248 | USD |
| CY2011Q2 | siga |
Contract Value Detail Of Option Exercisable Development Activities
ContractValueDetailOfOptionExercisableDevelopmentActivities
|
58300000 | USD |
| CY2011Q2 | siga |
Contract Value Detail Of Option Exercisable Production Activities
ContractValueDetailOfOptionExercisableProductionActivities
|
14400000 | USD |
| CY2018Q3 | siga |
Contract Value Detail Of Option Exercisable Production Activities
ContractValueDetailOfOptionExercisableProductionActivities
|
536200000 | USD |
| CY2018Q3 | siga |
Contract Value Of Development And Support Activities
ContractValueOfDevelopmentAndSupportActivities
|
32000000 | USD |
| CY2018Q3 | siga |
Contract Value Option Fda Approval
ContractValueOptionFDAApproval
|
50000000 | USD |
| CY2018 | siga |
Contract Value Option Fda Approval
ContractValueOptionFDAApproval
|
50000000 | USD |
| CY2011Q2 | siga |
Contract Valueof Various Options
ContractValueofVariousOptions
|
72700000 | USD |
| CY2016 | siga |
Conversionof Warrantsto Common Stock
ConversionofWarrantstoCommonStock
|
0 | USD |
| CY2017 | siga |
Conversionof Warrantsto Common Stock
ConversionofWarrantstoCommonStock
|
0 | USD |
| CY2018 | siga |
Conversionof Warrantsto Common Stock
ConversionofWarrantstoCommonStock
|
6007847 | USD |
| CY2018 | siga |
Costreimbusementand Fixed Fee Optionfor Postmarketing
CostreimbusementandFixedFeeOptionforPostmarketing
|
40800000 | USD |
| CY2016 | siga |
Decrease In Fair Value Of Warrants
DecreaseInFairValueOfWarrants
|
-894785 | USD |
| CY2017 | siga |
Decrease In Fair Value Of Warrants
DecreaseInFairValueOfWarrants
|
-4738753 | USD |
| CY2018 | siga |
Decrease In Fair Value Of Warrants
DecreaseInFairValueOfWarrants
|
-6922624 | USD |
| CY2017Q4 | siga |
Deferred Tax Liabilities Capitalized Contract Costs
DeferredTaxLiabilitiesCapitalizedContractCosts
|
21518646 | USD |
| CY2018Q4 | siga |
Deferred Tax Liabilities Capitalized Contract Costs
DeferredTaxLiabilitiesCapitalizedContractCosts
|
0 | USD |
| CY2016 | siga |
Effective Income Tax Rate Reconciliation Loss From Fair Value Of Common Warrants
EffectiveIncomeTaxRateReconciliationLossFromFairValueOfCommonWarrants
|
0.008 | |
| CY2017 | siga |
Effective Income Tax Rate Reconciliation Loss From Fair Value Of Common Warrants
EffectiveIncomeTaxRateReconciliationLossFromFairValueOfCommonWarrants
|
0.043 | |
| CY2018 | siga |
Effective Income Tax Rate Reconciliation Loss From Fair Value Of Common Warrants
EffectiveIncomeTaxRateReconciliationLossFromFairValueOfCommonWarrants
|
0.004 | |
| CY2016 | siga |
Effective Income Tax Rate Reconciliation Loss From Reorganization Costs
EffectiveIncomeTaxRateReconciliationLossFromReorganizationCosts
|
0.033 | |
| CY2017 | siga |
Effective Income Tax Rate Reconciliation Loss From Reorganization Costs
EffectiveIncomeTaxRateReconciliationLossFromReorganizationCosts
|
0.000 | |
| CY2018 | siga |
Effective Income Tax Rate Reconciliation Loss From Reorganization Costs
EffectiveIncomeTaxRateReconciliationLossFromReorganizationCosts
|
0.000 | |
| CY2016 | siga |
Gainon Saleof Prv
GainonSaleofPRV
|
0 | USD |
| CY2017 | siga |
Gainon Saleof Prv
GainonSaleofPRV
|
0 | USD |
| CY2018 | siga |
Gainon Saleof Prv
GainonSaleofPRV
|
78338826 | USD |
| CY2018Q3 | siga |
Government Contract Base Valueof Award For Deliveryof Courses
GovernmentContractBaseValueofAwardForDeliveryofCourses
|
11100000 | USD |
| CY2011Q2 | siga |
Government Contract Number Of Courses Purchased Under Modified Contract
GovernmentContractNumberOfCoursesPurchasedUnderModifiedContract
|
1700000 | contract |
| CY2018 | siga |
Government Contract Number Of Courses Purchased Under Modified Contract
GovernmentContractNumberOfCoursesPurchasedUnderModifiedContract
|
1700000 | contract |
| CY2018Q4 | siga |
Patent Preparation Fees
PatentPreparationFees
|
207000 | USD |
| CY2018 | siga |
Patent Preparation Fees
PatentPreparationFees
|
789489 | USD |
| CY2018Q4 | siga |
Proceeds From Manufacture And Physical Delivery Of Courses Government Contracts
ProceedsFromManufactureAndPhysicalDeliveryOfCoursesGovernmentContracts
|
459800000 | USD |
| CY2016 | siga |
Proceedsfrom Equity Rights Offering Net
ProceedsfromEquityRightsOfferingNet
|
34596468 | USD |
| CY2018 | siga |
Increase In Fair Value Of Warrants
IncreaseInFairValueOfWarrants
|
6922624 | USD |
| CY2016 | siga |
Interest Paidon Pharm Athene Liability
InterestPaidonPharmAtheneLiability
|
11668900 | USD |
| CY2017 | siga |
Interest Paidon Pharm Athene Liability
InterestPaidonPharmAtheneLiability
|
0 | USD |
| CY2018 | siga |
Interest Paidon Pharm Athene Liability
InterestPaidonPharmAtheneLiability
|
0 | USD |
| CY2017 | siga |
Inventory Write Downs
InventoryWriteDowns
|
686000 | USD |
| CY2016 | siga |
Net Proceedsfrom Saleof Priority Review Voucher
NetProceedsfromSaleofPriorityReviewVoucher
|
0 | USD |
| CY2017 | siga |
Net Proceedsfrom Saleof Priority Review Voucher
NetProceedsfromSaleofPriorityReviewVoucher
|
0 | USD |
| CY2018 | siga |
Net Proceedsfrom Saleof Priority Review Voucher
NetProceedsfromSaleofPriorityReviewVoucher
|
78338826 | USD |
| CY2016 | siga |
Net Realizationof Deferred Revenueand Costs Dueto Fda Approval
NetRealizationofDeferredRevenueandCostsDuetoFDAApproval
|
0 | USD |
| CY2011Q2 | siga |
Government Contract Numberof Additional Courses Purchased Under Modified Contract
GovernmentContractNumberofAdditionalCoursesPurchasedUnderModifiedContract
|
300000 | course |
| CY2018Q3 | siga |
Government Contract Numberof Paymentstobe Paid Upon Deliveryof Bulk Drug Substance
GovernmentContractNumberofPaymentstobePaidUponDeliveryofBulkDrugSubstance
|
3200000 | USD |
| CY2018 | siga |
Government Contract Numberof Paymentstobe Paid Upon Deliveryof Bulk Drug Substance
GovernmentContractNumberofPaymentstobePaidUponDeliveryofBulkDrugSubstance
|
3200000 | USD |
| CY2018Q3 | siga |
Government Contract Paymentsfor Supportive Procurement Activities
GovernmentContractPaymentsforSupportiveProcurementActivities
|
600000 | USD |
| CY2018Q3 | siga |
Government Contract Proceedsfrom Paymentsfor Courses
GovernmentContractProceedsfromPaymentsforCourses
|
600000000 | USD |
| CY2011Q2 | siga |
Government Contract Value Of Award1
GovernmentContractValueOfAward1
|
508700000 | USD |
| CY2018Q3 | siga |
Government Contract Value Of Award1
GovernmentContractValueOfAward1
|
600100000 | USD |
| CY2018Q3 | siga |
Governmentcontractbasevalueawardfordeliveryandsupportactivities
Governmentcontractbasevalueawardfordeliveryandsupportactivities
|
51700000 | USD |
| CY2016 | siga |
Income Taxes Paid Refund
IncomeTaxesPaidRefund
|
500975 | USD |
| CY2017 | siga |
Income Taxes Paid Refund
IncomeTaxesPaidRefund
|
325000 | USD |
| CY2018 | siga |
Income Taxes Paid Refund
IncomeTaxesPaidRefund
|
251961 | USD |
| CY2016 | siga |
Increase In Fair Value Of Warrants
IncreaseInFairValueOfWarrants
|
894785 | USD |
| CY2017 | siga |
Increase In Fair Value Of Warrants
IncreaseInFairValueOfWarrants
|
4738753 | USD |
| CY2017 | siga |
Net Realizationof Deferred Revenueand Costs Dueto Fda Approval
NetRealizationofDeferredRevenueandCostsDuetoFDAApproval
|
0 | USD |
| CY2018 | siga |
Net Realizationof Deferred Revenueand Costs Dueto Fda Approval
NetRealizationofDeferredRevenueandCostsDuetoFDAApproval
|
281950853 | USD |
| CY2018Q3 | siga |
Number Of Courses To Be Delivered1
NumberOfCoursesToBeDelivered1
|
1488000 | course |
| CY2018Q3 | siga |
Numberof Courses Delivered Options Final Drug Product
NumberofCoursesDeliveredOptionsFinalDrugProduct
|
35700 | course |
| CY2018 | siga |
Numberof Courses Ivfdp
NumberofCoursesIVFDP
|
20000 | course |
| CY2018Q3 | siga |
Numberof Courses Options Final Drug Product
NumberofCoursesOptionsFinalDrugProduct
|
20000 | course |
| CY2018 | siga |
Numberof Courses Options Final Drug Product
NumberofCoursesOptionsFinalDrugProduct
|
64000 | course |
| CY2018Q3 | siga |
Numberof Courses Storedas Vendor Managed Inventory
NumberofCoursesStoredasVendorManagedInventory
|
212000 | course |
| CY2018Q3 | siga |
Numberof Primary Manufacturing Steps
NumberofPrimaryManufacturingSteps
|
2 | step |
| CY2018Q3 | siga |
Numberofcoursesbasefinaldrugproduct
Numberofcoursesbasefinaldrugproduct
|
8000000 | USD |
| CY2016 | siga |
Patent Preparation Fees
PatentPreparationFees
|
909376 | USD |
| CY2017Q1 | siga |
Patent Preparation Fees
PatentPreparationFees
|
241000 | USD |
| CY2017Q2 | siga |
Patent Preparation Fees
PatentPreparationFees
|
197000 | USD |
| CY2017Q3 | siga |
Patent Preparation Fees
PatentPreparationFees
|
251000 | USD |
| CY2017Q4 | siga |
Patent Preparation Fees
PatentPreparationFees
|
221000 | USD |
| CY2017 | siga |
Patent Preparation Fees
PatentPreparationFees
|
909946 | USD |
| CY2018Q1 | siga |
Patent Preparation Fees
PatentPreparationFees
|
218000 | USD |
| CY2018Q2 | siga |
Patent Preparation Fees
PatentPreparationFees
|
178000 | USD |
| CY2018Q3 | siga |
Patent Preparation Fees
PatentPreparationFees
|
186000 | USD |
| CY2017 | siga |
Proceedsfrom Equity Rights Offering Net
ProceedsfromEquityRightsOfferingNet
|
0 | USD |
| CY2018 | siga |
Proceedsfrom Equity Rights Offering Net
ProceedsfromEquityRightsOfferingNet
|
0 | USD |
| CY2018Q4 | siga |
Proceedsfrom Saleof Priority Review Voucher
ProceedsfromSaleofPriorityReviewVoucher
|
80000000 | USD |
| CY2018 | siga |
Proceedsfrom Saleof Priority Review Voucher
ProceedsfromSaleofPriorityReviewVoucher
|
78300000 | USD |
| CY2016 | siga |
Proceedsfrom Term Loan Escrow Release
ProceedsfromTermLoanEscrowRelease
|
28694444 | USD |
| CY2017 | siga |
Proceedsfrom Term Loan Escrow Release
ProceedsfromTermLoanEscrowRelease
|
0 | USD |
| CY2018 | siga |
Proceedsfrom Term Loan Escrow Release
ProceedsfromTermLoanEscrowRelease
|
0 | USD |
| CY2017Q4 | siga |
Receivables Percentage
ReceivablesPercentage
|
1 | |
| CY2018Q4 | siga |
Receivables Percentage
ReceivablesPercentage
|
1 | |
| CY2016 | siga |
Rent Expense Facilities Lease
RentExpenseFacilitiesLease
|
1200000 | USD |
| CY2017 | siga |
Rent Expense Facilities Lease
RentExpenseFacilitiesLease
|
1000000 | USD |
| CY2018 | siga |
Rent Expense Facilities Lease
RentExpenseFacilitiesLease
|
700000 | USD |
| CY2016 | siga |
Reorganization Payments
ReorganizationPayments
|
4600000 | USD |
| CY2016 | siga |
Reorganization Professional Fees
ReorganizationProfessionalFees
|
1732521 | USD |
| CY2016 | siga |
Reorganization Trusteefees
ReorganizationTrusteefees
|
33000 | USD |
| CY2018Q4 | siga |
Researchand Development Future Aggregate Amount
ResearchandDevelopmentFutureAggregateAmount
|
15100000 | USD |
| CY2018 | siga |
Revenue Government Contract
RevenueGovernmentContract
|
90900000 | USD |
| CY2016Q4 | siga |
Share Based Compensation Arrangement By Share Based Payment Award Options Performance Based Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsPerformanceBasedNumber
|
200000 | shares |
| CY2016 | siga |
Stock Issuance Fees Expense
StockIssuanceFeesExpense
|
566779 | USD |
| CY2017 | siga |
Stock Issuance Fees Expense
StockIssuanceFeesExpense
|
4497271 | USD |
| CY2018 | siga |
Stock Issuance Fees Expense
StockIssuanceFeesExpense
|
4497273 | USD |
| CY2018 | siga |
Stock Issued During Period Shares Exerciseof Warrants
StockIssuedDuringPeriodSharesExerciseofWarrants
|
760000 | shares |
| CY2016 | siga |
Stock Issued During Period Value Backstop Agreement
StockIssuedDuringPeriodValueBackstopAgreement
|
1764240 | USD |
| CY2016 | siga |
Stock Issued During Period Value Rights Offering
StockIssuedDuringPeriodValueRightsOffering
|
34596469 | USD |
| CY2017Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
1328867 | USD |
| CY2018Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
1688488 | USD |
| CY2017Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
1802107 | USD |
| CY2018Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
1959133 | USD |
| CY2017Q4 | us-gaap |
Accrued Bonuses Current
AccruedBonusesCurrent
|
2538340 | USD |
| CY2018Q4 | us-gaap |
Accrued Bonuses Current
AccruedBonusesCurrent
|
2600839 | USD |
| CY2017Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
5481579 | USD |
| CY2018Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
9648917 | USD |
| CY2017Q4 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
381980 | USD |
| CY2018Q4 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
242043 | USD |
| CY2017Q4 | us-gaap |
Accrued Vacation Current
AccruedVacationCurrent
|
328588 | USD |
| CY2018Q4 | us-gaap |
Accrued Vacation Current
AccruedVacationCurrent
|
294794 | USD |
| CY2017Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
3346738 | USD |
| CY2018Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
3244861 | USD |
| CY2017Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
214229581 | USD |
| CY2018Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
218697872 | USD |
| CY2016 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
775541 | USD |
| CY2017 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
1101031 | USD |
| CY2018 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
2273177 | USD |
| CY2016 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
800000 | USD |
| CY2017 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
1100000 | USD |
| CY2018 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
2300000 | USD |
| CY2017Q4 | us-gaap |
Assets
Assets
|
144670379 | USD |
| CY2018Q4 | us-gaap |
Assets
Assets
|
203443741 | USD |
| CY2017Q4 | us-gaap |
Assets Current
AssetsCurrent
|
37364493 | USD |
| CY2016Q3 | us-gaap |
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
|
2.29 | |
| CY2016Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
| CY2018Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
| CY2016Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
600000000 | shares |
| CY2018Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
600000000 | shares |
| CY2016Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
79039000 | shares |
| CY2017 | us-gaap |
Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
|
1179 | USD |
| CY2018Q4 | us-gaap |
Assets Current
AssetsCurrent
|
121289845 | USD |
| CY2018Q4 | us-gaap |
Capital Units Authorized
CapitalUnitsAuthorized
|
620000000 | shares |
| CY2015Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
112711028 | USD |
| CY2016Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
28701824 | USD |
| CY2017Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
19857833 | USD |
| CY2018Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
100652809 | USD |
| CY2016 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
-56536982 | USD |
| CY2017 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
-19072460 | USD |
| CY2018 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
143295324 | USD |
| CY2015Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
112711028 | USD |
| CY2016Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
56174046 | USD |
| CY2017Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
37101586 | USD |
| CY2018Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
180396910 | USD |
| CY2018Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
80763350 | shares |
| CY2016Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
79039000 | shares |
| CY2018Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
80763350 | shares |
| CY2017Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
7904 | USD |
| CY2018Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
8076 | USD |
| CY2017Q4 | us-gaap |
Contract With Customer Liability
ContractWithCustomerLiability
|
378896803 | USD |
| CY2018Q4 | us-gaap |
Contract With Customer Liability
ContractWithCustomerLiability
|
4159946 | USD |
| CY2018 | us-gaap |
Contract With Customer Liability Change In Timeframe Performance Obligation Satisfied Revenue Recognized
ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized
|
-376356437 | USD |
| CY2018 | us-gaap |
Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Change In Measure Of Progress
ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress
|
-1780050 | USD |
| CY2018 | us-gaap |
Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
|
3399630 | USD |
| CY2016 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
0 | USD |
| CY2017 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
0 | USD |
| CY2018Q1 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
0 | USD |
| CY2018Q2 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
0 | USD |
| CY2018Q3 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
95166000 | USD |
| CY2018Q4 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
103000 | USD |
| CY2018 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
95268974 | USD |
| CY2018Q4 | us-gaap |
Cumulative Effect Of New Accounting Principle In Period Of Adoption
CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption
|
-223313 | USD |
| CY2016 | us-gaap |
Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
|
-5093 | USD |
| CY2017 | us-gaap |
Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
|
623060 | USD |
| CY2018 | us-gaap |
Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
|
-1326022 | USD |
| CY2016 | us-gaap |
Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
|
-6539 | USD |
| CY2017 | us-gaap |
Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
|
624239 | USD |
| CY2018 | us-gaap |
Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
|
-866850 | USD |
| CY2016 | us-gaap |
Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
|
-1446 | USD |
| CY2018 | us-gaap |
Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
|
-44761 | USD |
| CY2017Q4 | us-gaap |
Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
|
84130212 | USD |
| CY2018Q4 | us-gaap |
Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
|
0 | USD |
| CY2017Q4 | us-gaap |
Deferred Tax Assets Tax Credit Carryforwards Alternative Minimum Tax
DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax
|
2652250 | USD |
| CY2017Q4 | us-gaap |
Deferred Tax Assets Tax Credit Carryforwards Alternative Minimum Tax
DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax
|
2700000 | USD |
| CY2018Q4 | us-gaap |
Deferred Tax Assets Tax Credit Carryforwards Alternative Minimum Tax
DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax
|
1326228 | USD |
| CY2017Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense
DeferredTaxAssetsTaxDeferredExpense
|
205527 | USD |
| CY2018Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense
DeferredTaxAssetsTaxDeferredExpense
|
60535 | USD |
| CY2017Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
|
1001662 | USD |
| CY2018Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
|
508089 | USD |
| CY2017Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
102556657 | USD |
| CY2018Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
1051307 | USD |
| CY2017Q4 | us-gaap |
Deferred Tax Liabilities Goodwill And Intangible Assets Goodwill
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill
|
193458 | USD |
| CY2018 | us-gaap |
Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
|
459172 | USD |
| CY2016 | us-gaap |
Debtor Reorganization Items Legal And Advisory Professional Fees
DebtorReorganizationItemsLegalAndAdvisoryProfessionalFees
|
1951381 | USD |
| CY2017Q4 | us-gaap |
Deferred Costs
DeferredCosts
|
96592334 | USD |
| CY2018Q4 | us-gaap |
Deferred Costs
DeferredCosts
|
0 | USD |
| CY2016 | us-gaap |
Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
|
21252 | USD |
| CY2017 | us-gaap |
Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
|
-2724371 | USD |
| CY2018 | us-gaap |
Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
|
-9256661 | USD |
| CY2016 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
20423 | USD |
| CY2017 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
-2718029 | USD |
| CY2018 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
-9301422 | USD |
| CY2017Q4 | us-gaap |
Deferred Revenue
DeferredRevenue
|
1255318 | USD |
| CY2018Q4 | us-gaap |
Deferred Revenue
DeferredRevenue
|
4159946 | USD |
| CY2017Q4 | us-gaap |
Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
|
377641485 | USD |
| CY2018Q4 | us-gaap |
Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
|
0 | USD |
| CY2016 | us-gaap |
Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
|
-829 | USD |
| CY2017 | us-gaap |
Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
|
6342 | USD |
| CY2017Q4 | us-gaap |
Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
|
282213 | USD |
| CY2018Q4 | us-gaap |
Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
|
171044 | USD |
| CY2017Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
127800813 | USD |
| CY2018Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
13264102 | USD |
| CY2017Q4 | us-gaap |
Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
|
2431963 | USD |
| CY2018Q4 | us-gaap |
Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
|
11733385 | USD |
| CY2017Q4 | us-gaap |
Deferred Tax Assets Liabilities Net Noncurrent
DeferredTaxAssetsLiabilitiesNetNoncurrent
|
2431963 | USD |
| CY2018Q4 | us-gaap |
Deferred Tax Assets Liabilities Net Noncurrent
DeferredTaxAssetsLiabilitiesNetNoncurrent
|
11733385 | USD |
| CY2017Q4 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
25244156 | USD |
| CY2018Q4 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
12212795 | USD |
| CY2017Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
38087782 | USD |
| CY2018Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
9798319 | USD |
| CY2017Q4 | us-gaap |
Deferred Tax Assets Other
DeferredTaxAssetsOther
|
1024082 | USD |
| CY2018Q4 | us-gaap |
Deferred Tax Assets Other
DeferredTaxAssetsOther
|
1028083 | USD |
| CY2017Q4 | us-gaap |
Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
|
417085 | USD |
| CY2018Q4 | us-gaap |
Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
|
371804 | USD |
| CY2018 | us-gaap |
Interest Expense
InterestExpense
|
15478203 | USD |
| CY2017Q4 | us-gaap |
Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
|
957804 | USD |
| CY2018Q4 | us-gaap |
Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
|
957765 | USD |
| CY2017Q4 | us-gaap |
Inventory Net
InventoryNet
|
2983249 | USD |
| CY2018Q4 | us-gaap |
Inventory Net
InventoryNet
|
2908210 | USD |
| CY2017Q4 | us-gaap |
Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
|
-36235484 | USD |
| CY2018 | us-gaap |
Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
|
428730000 | USD |
| CY2018Q4 | us-gaap |
Deferred Tax Liabilities Goodwill And Intangible Assets Goodwill
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill
|
192146 | USD |
| CY2017Q4 | us-gaap |
Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
|
1100089 | USD |
| CY2018Q4 | us-gaap |
Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
|
287264 | USD |
| CY2016 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
174275 | USD |
| CY2017 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
132189 | USD |
| CY2018 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
69630 | USD |
| CY2016 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.69 | |
| CY2017Q4 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.46 | |
| CY2017 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.46 | |
| CY2018Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.15 | |
| CY2018Q2 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.09 | |
| CY2018Q3 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
4.85 | |
| CY2018Q4 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.65 | |
| CY2018 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0 | |
| CY2017Q1 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.11 | |
| CY2017Q2 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.10 | |
| CY2017Q3 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.12 | |
| CY2017Q4 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.13 | |
| CY2016 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.69 | |
| CY2017Q4 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.46 | |
| CY2017 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.46 | |
| CY2018Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.15 | |
| CY2018Q2 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.09 | |
| CY2018Q3 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
4.71 | |
| CY2018Q4 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.65 | |
| CY2018 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0 | |
| CY2016 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.000 | |
| CY2017 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
-0.055 | |
| CY2018 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
-0.025 | |
| CY2017Q4 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.35 | |
| CY2017Q4 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.21 | |
| CY2016 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
-0.350 | |
| CY2017 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
-0.350 | |
| CY2018 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.210 | |
| CY2016 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
0.301 | |
| CY2017 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
0.360 | |
| CY2018 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
-0.247 | |
| CY2016 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
|
0.000 | |
| CY2017 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
|
-0.051 | |
| CY2018 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
|
0.000 | |
| CY2016 | us-gaap |
Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
|
0.002 | |
| CY2017 | us-gaap |
Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
|
-0.018 | |
| CY2018 | us-gaap |
Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
|
0.000 | |
| CY2016 | us-gaap |
Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
|
0.006 | |
| CY2017 | us-gaap |
Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
|
-0.039 | |
| CY2018 | us-gaap |
Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
|
0.008 | |
| CY2018Q4 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
|
12381000 | USD |
| CY2017Q4 | us-gaap |
Furniture And Fixtures Gross
FurnitureAndFixturesGross
|
363588 | USD |
| CY2018Q4 | us-gaap |
Furniture And Fixtures Gross
FurnitureAndFixturesGross
|
377859 | USD |
| CY2016 | us-gaap |
Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
|
0 | USD |
| CY2017Q1 | us-gaap |
Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
|
0 | USD |
| CY2017Q2 | us-gaap |
Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
|
0 | USD |
| CY2017Q3 | us-gaap |
Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
|
-1225000 | USD |
| CY2017Q4 | us-gaap |
Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
|
0 | USD |
| CY2017 | us-gaap |
Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
|
-1225421 | USD |
| CY2018 | us-gaap |
Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
|
0 | USD |
| CY2017Q4 | us-gaap |
Goodwill
Goodwill
|
898334 | USD |
| CY2018Q4 | us-gaap |
Goodwill
Goodwill
|
898334 | USD |
| CY2016 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-39684076 | USD |
| CY2017 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-38329274 | USD |
| CY2018 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
411639556 | USD |
| CY2016 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
13884 | USD |
| CY2017 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
-2093790 | USD |
| CY2018 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
-10168272 | USD |
| CY2016 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
-177342 | USD |
| CY2017 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
-1847427 | USD |
| CY2018 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
1622331 | USD |
| CY2016 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-522360 | USD |
| CY2017 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-1352263 | USD |
| CY2018 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
49723 | USD |
| CY2016 | us-gaap |
Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
|
19712849 | USD |
| CY2017 | us-gaap |
Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
|
23943057 | USD |
| CY2018 | us-gaap |
Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
|
0 | USD |
| CY2016 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
112225534 | USD |
| CY2017 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
11412898 | USD |
| CY2018 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
3475714 | USD |
| CY2016 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
13762876 | USD |
| CY2017 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
-22690715 | USD |
| CY2018 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
-39 | USD |
| CY2016 | us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
-80928 | USD |
| CY2017 | us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
60084 | USD |
| CY2018 | us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
356713 | USD |
| CY2016 | us-gaap |
Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
|
-84228 | USD |
| CY2017 | us-gaap |
Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
|
-203654 | USD |
| CY2018 | us-gaap |
Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
|
422860 | USD |
| CY2016 | us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
330443 | USD |
| CY2017 | us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
1065573 | USD |
| CY2018 | us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
2222616 | USD |
| CY2016 | us-gaap |
Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
|
0 | shares |
| CY2017Q4 | us-gaap |
Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
|
0 | shares |
| CY2018 | us-gaap |
Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
|
2785177 | shares |
| CY2016 | us-gaap |
Interest Expense
InterestExpense
|
2395517 | USD |
| CY2017 | us-gaap |
Interest Expense
InterestExpense
|
14758140 | USD |
| CY2018Q4 | us-gaap |
Inventory Work In Process And Raw Materials
InventoryWorkInProcessAndRawMaterials
|
1950445 | USD |
| CY2017Q4 | us-gaap |
Inventory Work In Process And Raw Materials
InventoryWorkInProcessAndRawMaterials
|
2025445 | USD |
| CY2016 | us-gaap |
Inventory Write Down
InventoryWriteDown
|
0 | USD |
| CY2017 | us-gaap |
Inventory Write Down
InventoryWriteDown
|
536000 | USD |
| CY2018 | us-gaap |
Inventory Write Down
InventoryWriteDown
|
0 | USD |
| CY2017Q4 | us-gaap |
Leasehold Improvements Gross
LeaseholdImprovementsGross
|
2420028 | USD |
| CY2018Q4 | us-gaap |
Leasehold Improvements Gross
LeaseholdImprovementsGross
|
2420028 | USD |
| CY2017Q4 | us-gaap |
Liabilities
Liabilities
|
467808670 | USD |
| CY2018Q4 | us-gaap |
Liabilities
Liabilities
|
100529054 | USD |
| CY2017Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
144670379 | USD |
| CY2018Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
203443741 | USD |
| CY2016 | us-gaap |
Liabilities Assumed1
LiabilitiesAssumed1
|
5832624 | USD |
| CY2017 | us-gaap |
Liabilities Assumed1
LiabilitiesAssumed1
|
0 | USD |
| CY2018 | us-gaap |
Liabilities Assumed1
LiabilitiesAssumed1
|
0 | USD |
| CY2017Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
6810446 | USD |
| CY2018Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
11337405 | USD |
| CY2016 | us-gaap |
Liabilities Subject To Compromise Period Increase Decrease
LiabilitiesSubjectToCompromisePeriodIncreaseDecrease
|
-160072170 | USD |
| CY2017 | us-gaap |
Liabilities Subject To Compromise Period Increase Decrease
LiabilitiesSubjectToCompromisePeriodIncreaseDecrease
|
0 | USD |
| CY2018 | us-gaap |
Liabilities Subject To Compromise Period Increase Decrease
LiabilitiesSubjectToCompromisePeriodIncreaseDecrease
|
0 | USD |
| CY2016 | us-gaap |
Litigation Settlement Interest
LitigationSettlementInterest
|
11668900 | USD |
| CY2017 | us-gaap |
Litigation Settlement Interest
LitigationSettlementInterest
|
0 | USD |
| CY2018 | us-gaap |
Litigation Settlement Interest
LitigationSettlementInterest
|
0 | USD |
| CY2017Q4 | us-gaap |
Loans Payable
LoansPayable
|
71050324 | USD |
| CY2018Q4 | us-gaap |
Loans Payable
LoansPayable
|
75547597 | USD |
| CY2016 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
59087357 | USD |
| CY2017 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-585569 | USD |
| CY2018 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-3812561 | USD |
| CY2016 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
1188664 | USD |
| CY2017 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-100124 | USD |
| CY2018 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
78236562 | USD |
| CY2016 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-116813003 | USD |
| CY2017 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-18386767 | USD |
| CY2018 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
68871323 | USD |
| CY2016 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-39697960 | USD |
| CY2017Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-8615000 | USD |
| CY2017Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-7501000 | USD |
| CY2017Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-9816000 | USD |
| CY2017Q4 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-10303000 | USD |
| CY2017 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-36235484 | USD |
| CY2018Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-11582000 | USD |
| CY2018Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-7051000 | USD |
| CY2018Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
388050000 | USD |
| CY2018Q4 | us-gaap |
Net Income Loss
NetIncomeLoss
|
52391000 | USD |
| CY2018 | us-gaap |
Net Income Loss
NetIncomeLoss
|
421807828 | USD |
| CY2016 | us-gaap |
Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
|
-39697960 | USD |
| CY2016 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
102324 | USD |
| CY2017 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
16788 | USD |
| CY2018 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
78940985 | USD |
| CY2016 | us-gaap |
Notes Reduction
NotesReduction
|
46900000 | USD |
| CY2017 | us-gaap |
Notes Reduction
NotesReduction
|
0 | USD |
| CY2018 | us-gaap |
Notes Reduction
NotesReduction
|
0 | USD |
| CY2016 | us-gaap |
Operating Expenses
OperatingExpenses
|
46002584 | USD |
| CY2017 | us-gaap |
Operating Expenses
OperatingExpenses
|
31118129 | USD |
| CY2018 | us-gaap |
Operating Expenses
OperatingExpenses
|
121954384 | USD |
| CY2016 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-31014956 | USD |
| CY2017Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-4269000 | USD |
| CY2017Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-4059000 | USD |
| CY2017Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-5651000 | USD |
| CY2017Q4 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-4871000 | USD |
| CY2017 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-18849169 | USD |
| CY2018Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-4535000 | USD |
| CY2018Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-3710000 | USD |
| CY2018Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
368885000 | USD |
| CY2018Q4 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-5541000 | USD |
| CY2018 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
355099398 | USD |
| CY2018Q4 | us-gaap |
Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
|
3019928 | USD |
| CY2018Q4 | us-gaap |
Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
|
541376 | USD |
| CY2018Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
|
352000 | USD |
| CY2018Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
|
320774 | USD |
| CY2018Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
|
304000 | USD |
| CY2018Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
|
304000 | USD |
| CY2018Q4 | us-gaap |
Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
|
1197778 | USD |
| CY2018Q4 | us-gaap |
Operating Loss Carryforwards
OperatingLossCarryforwards
|
40300000 | USD |
| CY2017Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
793497 | USD |
| CY2018Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
904885 | USD |
| CY2017Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
702167 | USD |
| CY2018Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
1058880 | USD |
| CY2017Q4 | us-gaap |
Other Liabilities
OtherLiabilities
|
840253 | USD |
| CY2018Q4 | us-gaap |
Other Liabilities
OtherLiabilities
|
1263113 | USD |
| CY2016 | us-gaap |
Other Noncash Expense
OtherNoncashExpense
|
1764240 | USD |
| CY2017 | us-gaap |
Other Noncash Expense
OtherNoncashExpense
|
0 | USD |
| CY2018 | us-gaap |
Other Noncash Expense
OtherNoncashExpense
|
0 | USD |
| CY2016 | us-gaap |
Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
|
0 | USD |
| CY2017 | us-gaap |
Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
|
84000 | USD |
| CY2018 | us-gaap |
Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
|
0 | USD |
| CY2016 | us-gaap |
Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
|
3775546 | USD |
| CY2017 | us-gaap |
Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
|
0 | USD |
| CY2018 | us-gaap |
Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
|
0 | USD |
| CY2016 | us-gaap |
Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
428009 | USD |
| CY2017 | us-gaap |
Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
591067 | USD |
| CY2018Q4 | us-gaap |
Related Party Transaction Due From To Related Party
RelatedPartyTransactionDueFromToRelatedParty
|
200000 | USD |
| CY2018 | us-gaap |
Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
|
42935 | USD |
| CY2016 | us-gaap |
Reorganization Items
ReorganizationItems
|
3716902 | USD |
| CY2018Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
3416135 | USD |
| CY2017Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
138640 | USD |
| CY2016Q4 | us-gaap |
Restricted Cash Noncurrent
RestrictedCashNoncurrent
|
17333332 | USD |
| CY2017Q4 | us-gaap |
Restricted Cash Noncurrent
RestrictedCashNoncurrent
|
6542448 | USD |
| CY2018Q4 | us-gaap |
Restricted Cash Noncurrent
RestrictedCashNoncurrent
|
68292023 | USD |
| CY2017Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-537375776 | USD |
| CY2018Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-115791261 | USD |
| CY2018Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
171274 | USD |
| CY2018Q4 | us-gaap |
Related Party Transaction Due From To Related Party
RelatedPartyTransactionDueFromToRelatedParty
|
42935 | USD |
| CY2018Q1 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
200000 | USD |
| CY2018 | us-gaap |
Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
4074440 | USD |
| CY2016 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
23927 | USD |
| CY2017 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
100124 | USD |
| CY2018 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
102264 | USD |
| CY2018Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
20000000 | shares |
| CY2017Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
2019999 | USD |
| CY2018Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
4317615 | USD |
| CY2016 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
0 | USD |
| CY2017 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
89498 | USD |
| CY2018 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
261879 | USD |
| CY2018 | us-gaap |
Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
|
-6007847 | USD |
| CY2017Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
3485378 | USD |
| CY2017 | us-gaap |
Reorganization Items
ReorganizationItems
|
0 | USD |
| CY2018 | us-gaap |
Reorganization Items
ReorganizationItems
|
0 | USD |
| CY2016 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
19710673 | USD |
| CY2017Q1 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
6360000 | USD |
| CY2017Q2 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
5068000 | USD |
| CY2017Q3 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
2471000 | USD |
| CY2017Q4 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
2781000 | USD |
| CY2017 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
16679712 | USD |
| CY2018Q1 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
3008000 | USD |
| CY2018Q2 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
3312000 | USD |
| CY2018Q3 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
3723000 | USD |
| CY2018Q4 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
2973000 | USD |
| CY2018 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
13016183 | USD |
| CY2015Q4 | us-gaap |
Restricted Cash Current
RestrictedCashCurrent
|
0 | USD |
| CY2016Q4 | us-gaap |
Restricted Cash Current
RestrictedCashCurrent
|
10138890 | USD |
| CY2017Q4 | us-gaap |
Restricted Cash Current
RestrictedCashCurrent
|
10701305 | USD |
| CY2018Q4 | us-gaap |
Restricted Cash Current
RestrictedCashCurrent
|
11452078 | USD |
| CY2015Q4 | us-gaap |
Restricted Cash Noncurrent
RestrictedCashNoncurrent
|
0 | USD |
| CY2016 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
14987628 | USD |
| CY2017 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
12268960 | USD |
| CY2018 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
477053782 | USD |
| CY2018Q4 | us-gaap |
Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
|
58100000 | USD |
| CY2017Q1 | us-gaap |
Revenues
Revenues
|
5202000 | USD |
| CY2017Q2 | us-gaap |
Revenues
Revenues
|
4265000 | USD |
| CY2017Q3 | us-gaap |
Revenues
Revenues
|
1390000 | USD |
| CY2017Q4 | us-gaap |
Revenues
Revenues
|
1412000 | USD |
| CY2018Q1 | us-gaap |
Revenues
Revenues
|
1748000 | USD |
| CY2018Q2 | us-gaap |
Revenues
Revenues
|
2661000 | USD |
| CY2018Q3 | us-gaap |
Revenues
Revenues
|
471075000 | USD |
| CY2018Q4 | us-gaap |
Revenues
Revenues
|
1569000 | USD |
| CY2016 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
13713635 | USD |
| CY2017Q1 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
2870000 | USD |
| CY2017Q2 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
3058000 | USD |
| CY2017Q3 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
3094000 | USD |
| CY2017Q4 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
3281000 | USD |
| CY2017 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
12303050 | USD |
| CY2018Q1 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
3057000 | USD |
| CY2018Q2 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
2880000 | USD |
| CY2018Q3 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
3115000 | USD |
| CY2018Q4 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
3828000 | USD |
| CY2018 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
12879738 | USD |
| CY2016 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
775541 | USD |
| CY2017 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
1101031 | USD |
| CY2018 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
2273177 | USD |
| CY2010Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
|
2000000 | shares |
| CY2012Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
|
4500000 | shares |
| CY2017Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
|
8500000 | shares |
| CY2018 | us-gaap |
Stock And Warrants Issued During Period Value Preferred Stock And Warrants
StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
|
6000000 | USD |
| CY2016 | us-gaap |
Stock Issued1
StockIssued1
|
0 | USD |
| CY2017 | us-gaap |
Stock Issued1
StockIssued1
|
0 | USD |
| CY2018 | us-gaap |
Stock Issued1
StockIssued1
|
1681426 | USD |
| CY2015Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-284428550 | USD |
| CY2016Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-287418269 | USD |
| CY2017Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-323138291 | USD |
| CY2018Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
102914687 | USD |
| CY2016Q4 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
0 | USD |
| CY2017Q4 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
0 | USD |
| CY2018Q4 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
5738964 | USD |
| CY2018Q4 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
5700000 | USD |
| CY2018 | us-gaap |
Unrecognized Tax Benefits Decreases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions
|
0 | USD |
| CY2018 | us-gaap |
Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
|
0 | USD |
| CY2018 | us-gaap |
Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
|
5738964 | USD |
| CY2018 | us-gaap |
Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
|
0 | USD |
| CY2018 | us-gaap |
Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
|
101500000 | USD |
| CY2016 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
57188503 | shares |
| CY2017Q4 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
78874494 | shares |
| CY2017 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
78874494 | shares |
| CY2018 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
82708472 | shares |
| CY2016 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
57188503 | shares |
| CY2017Q4 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
78874494 | shares |
| CY2017 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
78874494 | shares |
| CY2018 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
79923295 | shares |
| CY2018 | us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Concentration of Credit Risk</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has cash in bank accounts that exceeds the Federal Deposit Insurance Corporation insured limits. The Company has not experienced any losses on its cash accounts and no allowance has been provided for potential credit losses because management believes that any such losses would be minimal, if any. </font></div></div> | |
| CY2018 | us-gaap |
Revenue Recognition Deferred Revenue
RevenueRecognitionDeferredRevenue
|
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Deferred Revenue</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">When the Company receives consideration, or such consideration is unconditionally due, prior to transferring goods or services to the customer under the terms of a sales contract, the Company records deferred revenue, which represents a contract liability. The Company recognizes deferred revenue as net revenues once control of goods and/or services has been transferred to the customer and all revenue recognition criteria have been met and any constraints have been resolved.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Historically, the Company deferred revenue in connection with the manufacture and delivery of oral TPOXX® under the 2011 BARDA Contract. Revenue recognition as of December 31, 2017 was constrained by the unquantifiable possibility of product replacement pursuant to the FDA Approval Replacement Obligation. On July 13, 2018, the FDA approved oral TPOXX® for the treatment of smallpox. As a result of FDA approval, the possibility of having to replace product pursuant to the FDA Approval Replacement Obligation was essentially eliminated and deemed to be remote since there was no difference between the approved product and the courses of oral TPOXX® that had already been delivered to the Strategic Stockpile. As such, deferred revenue as of December 31, 2017 associated with the 2011 BARDA Contract was recorded as product sales and supportive services during the year ended December 31, 2018.</font></div></div> | |
| CY2018 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and revenues and expenses during the periods reported. The most significant estimates include the variables used in the calculation of fair value of warrants granted or issued by the Company, reported amounts of revenue, and the valuation of deferred tax assets. Estimates and assumptions are reviewed periodically and the effects of revisions are reflected in the financial statements in the period they are determined to be necessary. Actual results could differ from these estimates.</font></div></div> |
